enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tamoxifen - Wikipedia

    en.wikipedia.org/wiki/Tamoxifen

    In a double-blind crossover study, patients were given either a placebo or tamoxifen (10 mg orally twice daily) for one month, in random order. Seven out of ten patients saw a reduction in gynecomastia size with tamoxifen (P < 0.005), and the overall reduction for the group was statistically significant (P < 0.01). [ 41 ]

  3. Template : Medications and dosages used in hormone therapy ...

    en.wikipedia.org/wiki/Template:Medications_and...

    0.5–5 mg/day Various: Estrogen: SC implant: 50–200 mg every 6–24 mos Estradiol valerate: Progynova: Estrogen: Oral: 2–10 mg/day Progynova: Estrogen: Sublingual: 1–8 mg/day Delestrogen [c] Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks Estradiol cypionate: Depo-Estradiol: Estrogen: IM, SC: 2–10 mg/wk or 5–20 mg every 2 wks ...

  4. Study of Tamoxifen and Raloxifene - Wikipedia

    en.wikipedia.org/wiki/Study_of_Tamoxifen_and...

    One of the largest breast cancer prevention studies ever, [2] it included 22,000 women in 400 medical centers in the United States and Canada. [3] [4] [5] The study concluded that raloxifene caused fewer side-effects and less endometrial cancer than tamoxifen.

  5. Template:Tamoxifen dosage and incidence of breast symptoms ...

    en.wikipedia.org/wiki/Template:Tamoxifen_dosage...

    10% 12 months: 99%: 95%: 84%: 56%: 38%: 19% Notes: Prevention of breast symptoms—specifically gynecomastia and breast pain—induced by 150 mg/day bicalutamide monotherapy with tamoxifen in 282 men with prostate cancer. Bicalutamide and tamoxifen were initiated at the same time (0 months).

  6. Exemestane - Wikipedia

    en.wikipedia.org/wiki/Exemestane

    Oral exemestane 25 mg/day for 2–3 years of adjuvant therapy was generally more effective than 5 years of continuous adjuvant tamoxifen in the treatment of postmenopausal women with early-stage estrogen receptor-positive/unknown receptor status breast in a large well-designed [citation needed] trial. Preliminary data from the open-label TEAM ...

  7. Selective estrogen receptor modulator - Wikipedia

    en.wikipedia.org/wiki/Selective_estrogen...

    Tamoxifen is a pure antiestrogenic trans-isomer and has differential actions at estrogen target tissues throughout the body. Tamoxifen is selectively antiestrogenic in the breast but estrogen-like in bones and endometrial cancer. [26] Tamoxifen undergo phase I metabolism in the liver by microsomal cytochrome P450 (CYP) enzymes.

  8. Afimoxifene - Wikipedia

    en.wikipedia.org/wiki/Afimoxifene

    Afimoxifene, also known as 4-hydroxytamoxifen (4-OHT) and by its tentative brand name TamoGel, is a selective estrogen receptor modulator (SERM) of the triphenylethylene group and an active metabolite of tamoxifen. [1] [2] [3] The drug is under development under the tentative brand name TamoGel as a topical gel for the treatment of hyperplasia ...

  9. Million Women Study - Wikipedia

    en.wikipedia.org/wiki/Million_women_study

    The Million Women Study is a multi-centre, population-based prospective cohort study of women aged 50 and over invited to routine breast cancer screening in the UK. Between 1996 and 2001, women were invited to join the Million Women Study when they received their invitation to attend breast screening at one of 66 participating NHS Breast Screening Centres in the UK.

  1. Related searches 10 mg tamoxifen effective study schedule for women pdf fillable free printable

    does tamoxifen workwhere to buy tamoxifen
    what does tamoxifen donolvadex tamoxifen
    tamoxifen wiki